nevirapine has been researched along with HIV Lipodystrophy Syndrome in 21 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 13 (61.90) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prendergast, AJ | 1 |
| Bhutia, E | 1 |
| Hemal, A | 1 |
| Yadav, TP | 1 |
| Ramesh, KL | 1 |
| Tebas, P | 1 |
| Zhang, J | 1 |
| Hafner, R | 1 |
| Tashima, K | 1 |
| Shevitz, A | 1 |
| Yarasheski, K | 1 |
| Berzins, B | 1 |
| Owens, S | 1 |
| Forand, J | 1 |
| Evans, S | 1 |
| Murphy, R | 1 |
| Negredo, E | 3 |
| Miró, O | 2 |
| Rodríguez-Santiago, B | 1 |
| Garrabou, G | 1 |
| Estany, C | 1 |
| Masabeu, A | 1 |
| Force, L | 1 |
| Barrufet, P | 1 |
| Cucurull, J | 1 |
| Domingo, P | 3 |
| Alonso-Villaverde, C | 1 |
| Bonjoch, A | 2 |
| Morén, C | 1 |
| Pérez-Alvarez, N | 1 |
| Clotet, B | 3 |
| van Griensven, J | 1 |
| Zachariah, R | 1 |
| Rasschaert, F | 1 |
| Mugabo, J | 1 |
| Atté, EF | 1 |
| Reid, T | 1 |
| Floridia, M | 1 |
| Tamburrini, E | 1 |
| Anzidei, G | 1 |
| Tibaldi, C | 1 |
| Guaraldi, G | 1 |
| Guerra, B | 1 |
| Meloni, AM | 1 |
| Vimercati, A | 1 |
| Molinari, A | 1 |
| Pinnetti, C | 1 |
| Dalzero, S | 1 |
| Ravizza, M | 1 |
| Mugyenyi, P | 3 |
| Walker, AS | 2 |
| Hakim, J | 3 |
| Munderi, P | 2 |
| Gibb, DM | 2 |
| Kityo, C | 2 |
| Reid, A | 2 |
| Grosskurth, H | 3 |
| Darbyshire, JH | 3 |
| Ssali, F | 2 |
| Bray, D | 2 |
| Katabira, E | 3 |
| Babiker, AG | 1 |
| Gilks, CF | 1 |
| Kabuye, G | 1 |
| Nsibambi, D | 2 |
| Kasirye, R | 1 |
| Zalwango, E | 1 |
| Nakazibwe, M | 1 |
| Kikaire, B | 1 |
| Nassuna, G | 1 |
| Massa, R | 1 |
| Fadhiru, K | 2 |
| Namyalo, M | 1 |
| Zalwango, A | 1 |
| Generous, L | 1 |
| Khauka, P | 2 |
| Rutikarayo, N | 1 |
| Nakahima, W | 1 |
| Mugisha, A | 1 |
| Todd, J | 1 |
| Levin, J | 1 |
| Muyingo, S | 1 |
| Ruberantwari, A | 1 |
| Kaleebu, P | 2 |
| Yirrell, D | 2 |
| Ndembi, N | 2 |
| Lyagoba, F | 2 |
| Hughes, P | 1 |
| Aber, M | 1 |
| Lara, AM | 2 |
| Foster, S | 2 |
| Amurwon, J | 2 |
| Wakholi, BN | 2 |
| Whitworth, J | 1 |
| Wangati, K | 1 |
| Amuron, B | 1 |
| Kajungu, D | 1 |
| Nakiyingi, J | 1 |
| Omony, W | 1 |
| Tumukunde, D | 1 |
| Otim, T | 1 |
| Kabanda, J | 1 |
| Musana, H | 1 |
| Akao, J | 1 |
| Kyomugisha, H | 1 |
| Byamukama, A | 1 |
| Sabiiti, J | 1 |
| Komugyena, J | 1 |
| Wavamunno, P | 1 |
| Mukiibi, S | 1 |
| Drasiku, A | 1 |
| Byaruhanga, R | 1 |
| Labeja, O | 1 |
| Katundu, P | 2 |
| Tugume, S | 2 |
| Awio, P | 1 |
| Namazzi, A | 1 |
| Bakeinyaga, GT | 1 |
| Katabira, H | 1 |
| Abaine, D | 1 |
| Tukamushaba, J | 1 |
| Anywar, W | 1 |
| Ojiambo, W | 1 |
| Angweng, E | 1 |
| Murungi, S | 2 |
| Haguma, W | 1 |
| Atwiine, S | 1 |
| Kigozi, J | 3 |
| Namale, L | 1 |
| Mukose, A | 1 |
| Mulindwa, G | 1 |
| Atwiine, D | 1 |
| Muhwezi, A | 1 |
| Nimwesiga, E | 1 |
| Barungi, G | 1 |
| Takubwa, J | 1 |
| Mwebesa, D | 1 |
| Kagina, G | 1 |
| Mulindwa, M | 1 |
| Ahimbisibwe, F | 1 |
| Mwesigwa, P | 1 |
| Akuma, S | 1 |
| Zawedde, C | 1 |
| Nyiraguhirwa, D | 1 |
| Tumusiime, C | 1 |
| Bagaya, L | 1 |
| Namara, W | 1 |
| Karungi, J | 1 |
| Kankunda, R | 1 |
| Enzama, R | 1 |
| Latif, A | 2 |
| Robertson, V | 2 |
| Chidziva, E | 1 |
| Bulaya-Tembo, R | 1 |
| Musoro, G | 1 |
| Taziwa, F | 1 |
| Chimbetete, C | 1 |
| Chakonza, L | 1 |
| Mawora, A | 1 |
| Muvirimi, C | 1 |
| Tinago, G | 1 |
| Svovanapasis, P | 1 |
| Simango, M | 1 |
| Chirema, O | 1 |
| Machingura, J | 1 |
| Mutsai, S | 1 |
| Phiri, M | 1 |
| Bafana, T | 1 |
| Chirara, M | 2 |
| Muchabaiwa, L | 2 |
| Muzambi, M | 2 |
| Mutowo, J | 1 |
| Chivhunga, T | 1 |
| Chigwedere, E | 1 |
| Pascoe, M | 1 |
| Warambwa, C | 1 |
| Zengeza, E | 1 |
| Mapinge, F | 1 |
| Makota, S | 1 |
| Jamu, A | 1 |
| Ngorima, N | 1 |
| Chirairo, H | 1 |
| Chitsungo, S | 1 |
| Chimanzi, J | 1 |
| Maweni, C | 1 |
| Warara, R | 1 |
| Matongo, M | 1 |
| Mudzingwa, S | 1 |
| Jangano, M | 1 |
| Moyo, K | 1 |
| Vere, L | 1 |
| Mdege, N | 1 |
| Machingura, I | 1 |
| Ronald, A | 1 |
| Kambungu, A | 1 |
| Lutwama, F | 1 |
| Mambule, I | 1 |
| Nanfuka, A | 1 |
| Walusimbi, J | 1 |
| Nabankema, E | 1 |
| Nalumenya, R | 1 |
| Namuli, T | 1 |
| Kulume, R | 1 |
| Namata, I | 1 |
| Nyachwo, L | 1 |
| Florence, A | 1 |
| Kusiima, A | 1 |
| Lubwama, E | 1 |
| Nairuba, R | 1 |
| Oketta, F | 1 |
| Buluma, E | 1 |
| Waita, R | 1 |
| Ojiambo, H | 1 |
| Sadik, F | 1 |
| Wanyama, J | 1 |
| Nabongo, P | 1 |
| Oyugi, J | 1 |
| Sematala, F | 1 |
| Muganzi, A | 1 |
| Twijukye, C | 1 |
| Byakwaga, H | 1 |
| Ochai, R | 1 |
| Muhweezi, D | 1 |
| Coutinho, A | 1 |
| Etukoit, B | 1 |
| Gilks, C | 2 |
| Boocock, K | 1 |
| Puddephatt, C | 1 |
| Grundy, C | 1 |
| Bohannon, J | 1 |
| Winogron, D | 1 |
| Burke, A | 1 |
| Babiker, A | 2 |
| Wilkes, H | 1 |
| Rauchenberger, M | 1 |
| Sheehan, S | 1 |
| Spencer-Drake, C | 1 |
| Taylor, K | 1 |
| Spyer, M | 1 |
| Ferrier, A | 1 |
| Naidoo, B | 1 |
| Dunn, D | 2 |
| Goodall, R | 2 |
| Peto, L | 1 |
| Nanfuka, R | 1 |
| Mufuka-Kapuya, C | 1 |
| Pillay, D | 1 |
| McCormick, A | 1 |
| Weller, I | 1 |
| Bahendeka, S | 1 |
| Bassett, M | 1 |
| Wapakhabulo, AC | 1 |
| Gazzard, B | 1 |
| Mapuchere, C | 1 |
| Mugurungi, O | 1 |
| Burke, C | 1 |
| Jones, S | 1 |
| Newland, C | 1 |
| Pearce, G | 1 |
| Rahim, S | 1 |
| Rooney, J | 1 |
| Smith, M | 1 |
| Snowden, W | 1 |
| Steens, JM | 1 |
| Breckenridge, A | 1 |
| McLaren, A | 1 |
| Hill, C | 1 |
| Matenga, J | 1 |
| Pozniak, A | 1 |
| Serwadda, D | 1 |
| Peto, T | 1 |
| Palfreeman, A | 1 |
| Borok, M | 1 |
| Zhou, HY | 1 |
| Zheng, YH | 1 |
| He, Y | 1 |
| Chen, Z | 1 |
| Liu, M | 1 |
| Yin, W | 1 |
| Liu, C | 1 |
| Feeney, ER | 1 |
| van Vonderen, MG | 1 |
| Wit, F | 1 |
| Danner, SA | 1 |
| van Agtmael, MA | 1 |
| Villarroya, F | 1 |
| Capeau, J | 1 |
| Reiss, P | 3 |
| Mallon, PW | 1 |
| Arpadi, S | 1 |
| Shiau, S | 1 |
| Strehlau, R | 1 |
| Martens, L | 1 |
| Patel, F | 1 |
| Coovadia, A | 1 |
| Abrams, EJ | 1 |
| Kuhn, L | 1 |
| Teruya, K | 1 |
| Oka, S | 1 |
| Boyle, BA | 1 |
| Moltó, J | 1 |
| Burger, D | 1 |
| Côté, H | 1 |
| Ribalta, J | 1 |
| Martínez, E | 1 |
| Puig, J | 1 |
| Ruiz, L | 2 |
| Salazar, J | 1 |
| López, S | 1 |
| Montaner, J | 1 |
| Rey-Joly, C | 1 |
| Nolan, D | 2 |
| Mallal, S | 1 |
| Montero, M | 1 |
| García-Gibert, L | 1 |
| Giménez-Arnau, AM | 1 |
| Knobel, H | 1 |
| Tin, EE | 1 |
| Bowonwatanuwong, C | 1 |
| Desakorn, V | 1 |
| Wilairatana, P | 1 |
| Krudsood, S | 1 |
| Pitisuttithum, P | 1 |
| Paredes, R | 1 |
| Tuldrà, A | 1 |
| Fumaz, CR | 1 |
| Gel, S | 1 |
| Garcés, B | 1 |
| Johnston, S | 1 |
| Arnó, A | 1 |
| Balagué, M | 1 |
| Jou, A | 1 |
| Tural, C | 1 |
| Sirera, G | 1 |
| Romeu, J | 1 |
| Cruz, L | 1 |
| Francia, E | 1 |
| Arrizabalaga, J | 1 |
| Ruiz, I | 1 |
| Arribas, JR | 1 |
| Arranz Caso, JA | 1 |
| López, JC | 1 |
| Santos, I | 1 |
| Estrada, V | 1 |
| Castilla, V | 1 |
| Sanz, J | 2 |
| Molina, JP | 1 |
| Fernández Guerrero, M | 1 |
| Górgolas, M | 1 |
| van Leth, F | 1 |
| Hall, DB | 1 |
| Lange, JM | 1 |
| Laurent, C | 1 |
| Bourgeois, A | 1 |
| Mpoudi-Ngolé, E | 1 |
| Ciaffi, L | 1 |
| Kouanfack, C | 1 |
| Mougnutou, R | 1 |
| Nkoué, N | 1 |
| Calmy, A | 1 |
| Koulla-Shiro, S | 1 |
| Delaporte, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Restrictively Randomized, Open-Label, Controlled, Pilot Study of the Effect of a Thymidine Analogue Substitution or Change to a Nucleoside-Sparing Regimen on Peripheral Fat Wasting[NCT00028314] | 150 participants | Interventional | 2002-03-31 | Completed | |||
| Randomised, Prospective Multicentre Clinical Study on the Effect of the Combination of Lopinavir/Rtv + Nevirapine as Maintenance Bitherapy (Without Nucleoside Analogues) in Comparison With a Triple Therapy Including Lopinavir/Rtv + Nucleoside Analogues in[NCT00335686] | Phase 4 | 67 participants (Actual) | Interventional | 2003-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for nevirapine and HIV Lipodystrophy Syndrome
| Article | Year |
|---|---|
[Antiretrovirals].
Topics: Acidosis, Lactic; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Hemophilia A; H | 2003 |
Issues in antiretroviral toxicity.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Exanthema; Female; HIV | 2003 |
Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics.
Topics: Adenine; Alkynes; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardi | 2005 |
Do non-nucleoside reverse transcriptase inhibitors contribute to lipodystrophy?
Topics: Alkynes; Anti-Retroviral Agents; Benzoxazines; Cardiovascular Diseases; Cyclopropanes; HIV Infection | 2005 |
10 trials available for nevirapine and HIV Lipodystrophy Syndrome
| Article | Year |
|---|---|
Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Female; HIV Infections; HIV-Associated Li | 2009 |
Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
Topics: Absorptiometry, Photon; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composit | 2009 |
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
Topics: Adenine; Adolescent; Adult; Africa; Aged; Anemia; Anti-Retroviral Agents; CD4 Lymphocyte Count; Crea | 2010 |
Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents | 2012 |
Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy.
Topics: Anti-HIV Agents; Body Composition; Child; Child, Preschool; Cross-Sectional Studies; Drug Therapy, C | 2013 |
Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study).
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cholesterol, HDL; Cholesterol, LDL; D | 2005 |
The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients.
Topics: Adolescent; Adult; Age Factors; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antire | 2005 |
Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.
Topics: Adult; Anthropometry; Anti-HIV Agents; Body Size; Drug Administration Schedule; Drug Therapy, Combin | 1999 |
A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; Follow- | 2005 |
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combin | 2008 |
7 other studies available for nevirapine and HIV Lipodystrophy Syndrome
| Article | Year |
|---|---|
Complications of long-term antiretroviral therapy in HIV-infected children.
Topics: Anti-HIV Agents; Body Composition; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Hu | 2013 |
Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern India.
Topics: Adolescent; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; | 2014 |
Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda.
Topics: Acidosis, Lactic; Adult; Age Factors; Anti-HIV Agents; Drug Therapy, Combination; Drugs, Generic; Ex | 2010 |
Plasma lipid profile in pregnant women with HIV receiving nevirapine.
Topics: Adolescent; Adult; Anti-HIV Agents; Cholesterol; Drug Therapy, Combination; Female; HIV Infections; | 2009 |
Evaluation of a 6-year highly active antiretroviral therapy in Chinese HIV-1-infected patients.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; China; Chole | 2010 |
[Toxic epidermal necrolysis associated with abacavir].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Didanosine; Dideoxynucleosides; HIV I | 2005 |
Plasma lipid concentrations after 1.5 years of exposure to nevirapine or efavirenz together with stavudine and lamivudine.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cholesterol; Cyclopropanes; Drug Therapy, Combination; HIV I | 2006 |